key: cord-0945602-daurqklv authors: Catriona, Chaplin; Paolo, Pozzilli title: SARS‐CoV‐2 induced post‐translational protein modifications: A trigger for developing autoimmune diabetes? date: 2022-01-06 journal: Diabetes Metab Res Rev DOI: 10.1002/dmrr.3508 sha: d36d881d461aef9e98ac83501f84322f9832082e doc_id: 945602 cord_uid: daurqklv Emerging evidence indicates a bi‐directional relationship between SARS‐CoV‐2 and diabetes. The possibility exists that SARS‐CoV‐2 could induce diabetes, but it is not yet clear whether this might be a fulminant‐type diabetes, autoimmune diabetes, or a new‐onset transient hyperglycaemia. This viewpoint discusses mechanisms by which SARS‐CoV‐2 might trigger type 1 diabetes mellitus (T1DM). Specifically, we looked at the role of post‐translational protein modifications (PTMs) and the generation of neoepitopes as a potential mechanism in the induction of islet autoimmunity, and the pathways via which coronavirus infections might exacerbate the formation of PTMs and, in so doing, provoke the onset of T1DM. Post-translational protein modifications (PTMs) are essential for normal cellular functioning. However, such modifications can also enable a breaking of central tolerance through the generation of neoepitopes that provide novel determinants able to activate T-cells. This phenomenon is well recognised in the pathogenesis of autoimmune conditions including rheumatoid arthritis (RA) 10 and coeliac disease. 11 Several antibodies to post-translationally modified islet peptides have now been identified 12 (Table 1) . Indeed, antibodies to post-translationally modified insulin are not only more abundant than those to native insulin in newly diagnosed T1DM patients 13 but are also more sensitive and specific biomarkers of disease progression when compared to standard islet autoantibodies. 14 As such, their potential importance in the pathogenesis of T1DM is increasingly recognised. Several mechanisms by which SARS-CoV-2 might trigger islet autoimmunity have been suggested, including molecular mimicry and prolonged presentation of β-cell epitopes secondary to overexpression of HLA Class I. 24 At present, less attention has been paid as to how viral infections might trigger T1DM by driving increased activity in pathways enhancing post-translational modifications and the production of neo-epitopes. We suggest mechanisms by which viral infections generally, and SARS-CoV-2 in particular, may enhance the formation of neoepitopes and, in doing so, trigger islet autoimmunity in genetically susceptible individuals. These mechanisms relate to (a) islet inflammation and oxidative stress (b) initiation of endoplasmic reticulum (ER) stress and (c) aberrant NETosis (see It is now thought that severe disease in COVID-19 is the consequence of the body's own hyper-inflammatory response to the virus, which involves the secretion of a plethora of cytokines -the 'cytokine storm'. Whether SARS-CoV-2 can directly infect islet cells to induce inflammation is currently unresolved. Whilst cellular entry of SARS-CoV-2 is thought to be dependent upon ACE-II receptors 26 and expression of this receptor has been identified in pancreatic β-cells, 27 other studies suggest that β-cell expression may be of insufficient levels to enable viral entry and resulting βcell damage. 28 Receptors such as Neuropilin-1, which are expressed at high levels by β-cells may, however, provide alternative means of facilitating SARS-CoV-2 entry. 29 In vivo evidence of SARS-CoV-2 infecting β-cells is still relatively limited, although a new study has identified SARs-CoV-2 antigens within NKX6.1- This oxidative stress may modify proteins directly or, indirectly, through the effect of ROS on downstream cellular pathways. 30 There is evidence that pancreatic inflammation can induce both enzymatic and non-enzymatic PTMs. Experiments exposing human islets to inflammatory cytokines (IL-1β, IFN-γ and TNF-alpha) found them to contain deamidated C-peptides 19 and citrullinated GRP78, a T1DM autoantigen. 16 Pancreatic inflammation can also generate oxidative modifications; human islets cultured with INF-γ, IL-1β and TNF-α have been found to contain elevated levels of carbonyl-modified P4Hb, 23 also a known T1DM autoantigen. 30 Given P4Hb's role in insulin folding, such a modification may lead to abnormal insulin production, hyperglycaemia and the generation of ER stress which, as described below, may also enhance PTMs. 34 It has also been shown that excess ER stress can enhance neoepitope formation and precipitate immunogenicity. 35 The mechanism via which this occurs results from a cytosolic Ca 2+ influx in response to ER stress, which leads to activation of calcium-dependent PTM enzymes including tissue-transglutaminase (tTG) and Peptidyl Arginine Deiminases (PAD). 35 Viral infections may exacerbate PTMs directly, through disrupting ER membranes which then leak calcium ions, or indirectly, through triggering inflammatory processes which generate ER stress. With regards to SARS-CoV-2, in the knowledge that hyperglycaemia and glucotoxicity may also generate ER stress, 35 it is possible that a SARS-CoV-2 associated dysglycaemia could contribute to increased ER stress, activation of tTG and PAD enzymes and the production of neoepitopes. Indeed, SARS-CoV2-2 has already been noted to influence the activity of PAD enzymes; a study analysing the transcriptome of human lung biopsy samples from SARS-CoV-2 positive individuals found altered expression of PAD4 and PAD2 enzymes. 36 Furthermore, a study mapping the interactions between SARS-CoV-2 and human proteins identified several interacting proteins associated with ER protein quality control, morphology and the ER stress response. 37 NETosis is a feature of the COVID-19 and diabetes mellitus: an unholy interaction of two pandemics Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19 Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care Has Covid-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study Diverse functional autoantibodies in patients with COVID-19 The SARS-CoV-2 as an instrumental trigger of autoimmunity Rheumatoid arthritis and citrullination Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders Immune recognition of bcells: neoepitopes as key players in the loss of tolerance Antibodies to post-translationally modified insulin in type 1 diabetes Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies. Diabetes/Metabolism Research and Reviews Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes Citrullinated glucoseregulated protein 78 is an autoantigen in type 1 diabetes Inflammation-induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4 + T cells in patients with type 1 diabetes Human islets and dendritic cells generate post-translationally modified islet autoantigens Identification of unique antigenic determinants in the amino terminus of IA-2 (ICA512) in childhood and adult autoimmune diabetes: new biomarker development Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes The insulin A-chain epitope recognized by human T cells is posttranslationally modified Posttranslational modification of islet autoantigens in type 1 diabetes Type 1 diabetes triggered by Covid-19 pandemic: a potential outbreak? SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19 SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment Oxidative modifications in tissue pathology and autoimmune disease SARS-CoV-2 infection: the role of cytokines in COVID-19 disease Radicals and oxidative stress in diabetes Mallone R, Eizirik DL. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes? Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases Environmental factors contribute to β cell endoplasmic reticulum stress and neo-antigen formation in type 1 diabetes Putative roles for peptidylarginine deiminases in COVID-19 A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. bioRxiv NETosis as source of autoantigens in rheumatoid arthritis Netosis contributes to the pathogenesis of diabetes and its complications NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis